Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005.

2.50
Hdl Handle:
http://hdl.handle.net/10541/71037
Title:
Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005.
Authors:
Geraci, Marco; Birch, Jillian M; Alston, Robert D; Moran, Anthony; Eden, Tim O B
Abstract:
We examined cancer mortality at ages 13-29 years in England and Wales between 1981 and 2005, a total of 20 026 deaths over approximately 303 million person-years (mpy) at risk by sex, age group and time period. Overall, the mortality rate was 65.6 per mpy. Malignant neoplasms of the central nervous system showed the highest rate (8.5), followed by myeloid and monocytic leukaemia (6.6), lymphoid leukaemia (6.4), malignant bone tumours (5.4) and non-Hodgkin's lymphoma (5.2). These groups together accounted for almost 50% of all cancer deaths. The mortality rate for males (72.4) was 23% higher than for females (58.6) (P-value <0.0001). Males showed significantly higher mortality rates than females in almost all diagnostic groups, in general, mortality increasing with age (P-value <0.0001). There were significant decreases in mortality over time, the annual percentage change between 1981 and 2005 being minus 1.86 (95% confidence interval -2.09 to -1.62). Cancer groups with the highest mortality differed from those with the highest incidence.
Affiliation:
Cancer Research UK Paediatric and Familial Cancer Research Group, School of Cancer and Imaging Sciences, University of Manchester, Stancliffe, Hospital Road, Manchester M27 4HA, UK. Marco.Geraci@manchester.ac.uk
Citation:
Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005. 2007, 97 (11):1588-94 Br. J. Cancer
Journal:
British Journal of Cancer
Issue Date:
3-Dec-2007
URI:
http://hdl.handle.net/10541/71037
DOI:
10.1038/sj.bjc.6604080
PubMed ID:
17987032
Type:
Article
Language:
en
ISSN:
0007-0920
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorGeraci, Marco-
dc.contributor.authorBirch, Jillian M-
dc.contributor.authorAlston, Robert D-
dc.contributor.authorMoran, Anthony-
dc.contributor.authorEden, Tim O B-
dc.date.accessioned2009-06-19T13:31:01Z-
dc.date.available2009-06-19T13:31:01Z-
dc.date.issued2007-12-03-
dc.identifier.citationCancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005. 2007, 97 (11):1588-94 Br. J. Canceren
dc.identifier.issn0007-0920-
dc.identifier.pmid17987032-
dc.identifier.doi10.1038/sj.bjc.6604080-
dc.identifier.urihttp://hdl.handle.net/10541/71037-
dc.description.abstractWe examined cancer mortality at ages 13-29 years in England and Wales between 1981 and 2005, a total of 20 026 deaths over approximately 303 million person-years (mpy) at risk by sex, age group and time period. Overall, the mortality rate was 65.6 per mpy. Malignant neoplasms of the central nervous system showed the highest rate (8.5), followed by myeloid and monocytic leukaemia (6.6), lymphoid leukaemia (6.4), malignant bone tumours (5.4) and non-Hodgkin's lymphoma (5.2). These groups together accounted for almost 50% of all cancer deaths. The mortality rate for males (72.4) was 23% higher than for females (58.6) (P-value <0.0001). Males showed significantly higher mortality rates than females in almost all diagnostic groups, in general, mortality increasing with age (P-value <0.0001). There were significant decreases in mortality over time, the annual percentage change between 1981 and 2005 being minus 1.86 (95% confidence interval -2.09 to -1.62). Cancer groups with the highest mortality differed from those with the highest incidence.en
dc.language.isoenen
dc.subjectCanceren
dc.subject.meshAdolescent-
dc.subject.meshAdult-
dc.subject.meshEngland-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMortality-
dc.subject.meshNeoplasms-
dc.subject.meshRegistries-
dc.subject.meshWales-
dc.titleCancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005.en
dc.typeArticleen
dc.contributor.departmentCancer Research UK Paediatric and Familial Cancer Research Group, School of Cancer and Imaging Sciences, University of Manchester, Stancliffe, Hospital Road, Manchester M27 4HA, UK. Marco.Geraci@manchester.ac.uken
dc.identifier.journalBritish Journal of Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.